Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis.

Hai FengXueming ChenXiaobo GuoZhe ZhangZhiwen ZhangBin LiuLishan Lian

Published in: BMC cardiovascular disorders (2020)

DEB yielded additional benefits on MLD, LLL, primary patency, restenosis, TLR, and major adverse events than UCB in patients with femoropopliteal arterial occlusive disease.

Keyphrases

sickle cell disease
toll like receptor
inflammatory response